Literature DB >> 18635759

Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex.

Atsushi Matsuzawa1, Ping-Hui Tseng, Sivakumar Vallabhapurapu, Jun-Li Luo, Weizhou Zhang, Haopeng Wang, Dario A A Vignali, Ewen Gallagher, Michael Karin.   

Abstract

Cytokine signaling is thought to require assembly of multicomponent signaling complexes at cytoplasmic segments of membrane-embedded receptors, in which receptor-proximal protein kinases are activated. Indeed, CD40, a tumor necrosis factor receptor (TNFR) family member, forms a complex containing adaptor molecules TRAF2 and TRAF3, ubiquitin-conjugating enzyme Ubc13, cellular inhibitor of apoptosis proteins 1 and 2 (c-IAP1/2), IkappaB kinase regulatory subunit IKKgamma (also called NEMO), and mitogen-activated protein kinase (MAPK) kinase kinase MEKK1 upon ligation. TRAF2, Ubc13, and IKKgamma were required for complex assembly and activation of MEKK1 and MAPK cascades. However, these kinases were not activated unless the multicomponent signaling complex translocated from CD40 to the cytosol upon c-IAP1/2-induced degradation of TRAF3. This two-stage signaling mechanism may apply to other innate immune receptors, accounting for spatial and temporal separation of MAPK and IKK signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18635759      PMCID: PMC2669719          DOI: 10.1126/science.1157340

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  33 in total

Review 1.  Mammalian MAP kinase signalling cascades.

Authors:  L Chang; M Karin
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

Review 2.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 3.  SH2 domains, interaction modules and cellular wiring.

Authors:  T Pawson; G D Gish; P Nash
Journal:  Trends Cell Biol       Date:  2001-12       Impact factor: 20.808

Review 4.  The molecular architecture of the TNF superfamily.

Authors:  Jean-Luc Bodmer; Pascal Schneider; Jürg Tschopp
Journal:  Trends Biochem Sci       Date:  2002-01       Impact factor: 13.807

5.  TAK1 is a ubiquitin-dependent kinase of MKK and IKK.

Authors:  C Wang; L Deng; M Hong; G R Akkaraju; J Inoue ; Z J Chen
Journal:  Nature       Date:  2001-07-19       Impact factor: 49.962

6.  TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2.

Authors:  Xiaoming Li; Yili Yang; Jonathan D Ashwell
Journal:  Nature       Date:  2002-03-21       Impact factor: 49.962

7.  The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation.

Authors:  A Devin; A Cook; Y Lin; Y Rodriguez; M Kelliher; Z Liu
Journal:  Immunity       Date:  2000-04       Impact factor: 31.745

Review 8.  Signal transduction by tumor necrosis factor and its relatives.

Authors:  V Baud; M Karin
Journal:  Trends Cell Biol       Date:  2001-09       Impact factor: 20.808

Review 9.  TNF-R1 signaling: a beautiful pathway.

Authors:  Guoqing Chen; David V Goeddel
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

10.  Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].

Authors:  Chuan-Jin Wu; Dietrich B Conze; Tao Li; Srinivasa M Srinivasula; Jonathan D Ashwell
Journal:  Nat Cell Biol       Date:  2006-03-19       Impact factor: 28.824

View more
  104 in total

1.  The use of small molecule probes to study spatially separated stimulus-induced signaling pathways.

Authors:  Vladimir V Kravchenko; Christian Gloeckner; G Neil Stowe; Young J Kang; Peter S Tobias; John C Mathison; Richard J Ulevitch; Gunnar F Kaufmann; Kim D Janda
Journal:  Bioorg Med Chem Lett       Date:  2012-01-14       Impact factor: 2.823

Review 2.  Peli: a family of signal-responsive E3 ubiquitin ligases mediating TLR signaling and T-cell tolerance.

Authors:  Wei Jin; Mikyoung Chang; Shao-Cong Sun
Journal:  Cell Mol Immunol       Date:  2012-02-06       Impact factor: 11.530

Review 3.  Deciphering the complexity of Toll-like receptor signaling.

Authors:  Renato Ostuni; Ivan Zanoni; Francesca Granucci
Journal:  Cell Mol Life Sci       Date:  2010-07-31       Impact factor: 9.261

Review 4.  Oncogenic activation of NF-kappaB.

Authors:  Louis M Staudt
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

5.  Different strains of Theiler's murine encephalomyelitis virus antagonize different sites in the type I interferon pathway.

Authors:  Spyridon Stavrou; Zongdi Feng; Stanley M Lemon; Raymond P Roos
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

6.  To respond or not to respond to CD40 agonism: That is the prediction.

Authors:  Xiaoyan Shi; David Dornan
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

Review 7.  Scaffold proteins and immune-cell signalling.

Authors:  Andrey S Shaw; Erin L Filbert
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

8.  Analysis of nondegradative protein ubiquitylation with a monoclonal antibody specific for lysine-63-linked polyubiquitin.

Authors:  Haopeng Wang; Atsushi Matsuzawa; Scott A Brown; JingRan Zhou; Cliff S Guy; Ping-Hui Tseng; Karen Forbes; Thomas P Nicholson; Paul W Sheppard; Hans Häcker; Michael Karin; Dario A A Vignali
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-17       Impact factor: 11.205

9.  RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors.

Authors:  Zhenqiang Yao; Wei Lei; Rong Duan; Yanyun Li; Lu Luo; Brendan F Boyce
Journal:  J Biol Chem       Date:  2017-04-24       Impact factor: 5.157

10.  Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.

Authors:  Sivakumar Vallabhapurapu; Atsushi Matsuzawa; Weizhou Zhang; Ping-Hui Tseng; Jonathan J Keats; Haopeng Wang; Dario A A Vignali; P Leif Bergsagel; Michael Karin
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.